HPIV3-EbovZ GP Ebola vaccine

HPIV3-EbovZ GP · National Institute of Allergy and Infectious Diseases (NIAID)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HPIV3-EbovZ GP Ebola vaccine, covering 2017-02-01 to 2017-02-01. Get the full timeline:

Most recent: Clinical Trial Update: Evaluating the Safety of and Immune Response to a Human Parainfluenza Virus Type 3 Ebola Virus Vaccine (HPIV3-EbovZ GP) in Healthy Adults [Phase 1]

See pricing